Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Oxonica’s Successful Placing on AIM

Shares will commence trading on AIM today

Oxonica’s Successful Placing on AIM


July 20, 2005

Oxonica plc (“Oxonica”), the holding company of one of Europe’s leading nanomaterials groups, announces that following a successful placing, its ordinary shares will commence trading on AIM today.


  • Oxonica has raised approximately £7.1 million (net of expenses) through a placing of 8,658,796 new Ordinary Shares at 95.8 pence per share
  • In addition, Oxonica shareholders have converted loans of approximately £2.0 million into Ordinary Shares at 95.8 pence per share, which together with the placing strengthens the balance sheet by £9.1 million
  • The placing shares will represent approximately 23.5 per cent of the enlarged share capital of Oxonica following admission of its Ordinary Shares to AIM
  • On Admission, Oxonica will have a market capitalisation of approximately £35.3 million
  • The lead investors in the placing have been Richard Farleigh, Foresight 2 VCT plc, and Stagecoach Group plc
  • Oxonica is admitting its ordinary shares to trading on AIM to raise additional capital for Group development. Admission to AIM will also raise its profile internationally with customers and suppliers and assist in the recruitment, retention and incentivisation of employees
  • Oxonica focuses on the development of innovative commercial solutions for international markets using its expertise in the design and application of nanomaterials
  • The net proceeds will help to develop and market Oxonica’s commercial solutions, including the current products Optisol™ and Envirox™, worldwide, to carry out any additional required product testing, to add to its research capabilities, to invest in the further commercialisation of Oxonica’s UV protection technology and to accelerate the development of its biomarker technology
  • The number of Ordinary Shares in issue following Admission will be 36,805,329
  • Oxonica will have a RIC code of OXN.L
  • Panmure Gordon & Co are nominated adviser and broker to Oxonica

Commenting on the Placing and Admission, Dr Kevin Matthews, Chief Executive of Oxonica said:
“We are delighted both to have had such a positive response to our fundraising and with today's admission to AIM. The listing and strengthened balance sheet will enhance our profile and visibility with global strategic partners as we seek to develop innovative nanotechnology solutions internationally. Oxonica is already well positioned within the nanotechnology market and we are excited about the future prospects of this evolving industry.”


About Oxonica plc:
Oxonica is one of the leading European nanomaterials groups with products already launched into international markets. It was spun-out from Oxford University in 1999 and currently employs 37 professional staff.

Oxonica’s mission is to develop innovative commercial solutions for international markets using its expertise in the design and application of nanomaterials.

The company has three operating divisions: Oxonica Energy, Oxonica Healthcare and Oxonica Materials.

Commercialised products are:

Envirox™ Fuel Borne Catalyst – a fuel borne nanocatalyst for diesel engines which reduces fuel consumption with savings of 5-10% and reduces particulate emissions by up to 15%. The product has already been adopted by Stagecoach Group in the UK and in New Zealand and is distributed by DMX Technology Corporation to petroleum companies in the Philippines for use in a premium diesel.

Optisol™ UV Absorber – a photostable UV absorber that provides enhanced and longer lasting protection against UVA in sun-care and anti-ageing products. Optisol™ also reduces the formation of free radicals produced from exposure to the sun and which are implicated in premature skin ageing. Boots Group plc is the first to incorporate Optisol™ in their new Soltan Facial Sun Defense Cream for 2005.

In addition, Oxonica is working to generate a range of future product applications. These include additional fuel saving additives, marker technology for the clinical and life science diagnostics markets, further UV protection applications, including tailoring the Optisol™ product in the cosmetics markets, and new products for plastics and coatings, transparent conducting films and security markers.

Optisol™ and Envirox™ are trademarks of Oxonica.

For more information, please visit

Internal PR Contact:
Sonia Bouzid
PR & Marketing Communications Manager
+44 1865 856 728

External PR Contact:
Nigel Robson
Vortex PR
+44 1481 233 080

Copyright © Oxonica plc

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Nanometrics Announces Upcoming Investor Events November 18th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces Multi-Year Agreement With Lockheed Martin November 16th, 2015

Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA November 16th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces the Sale of Its Latest Quantum Computer to Los Alamos National Laboratory November 11th, 2015


Physicists explain the unusual behavior of strongly disordered superconductors: Using a theory they developed previously, the scientists have linked superconducting carrier density with the quantum properties of a substance November 25th, 2015

Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015

Researchers find new, inexpensive way to clean water from oil sands production November 24th, 2015

Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015

Financial Reports

Haydale Announce Year End Results November 3rd, 2015

Harris & Harris Group to Host Conference Call on Third-Quarter 2015 Financial Results on November 12, 2015 October 23rd, 2015

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

Nanostart AG: First-half figures 2015 published and new supervisory board elected : Publication of first-half figures 2015 - Shareholders' meeting elected new supervisory board August 22nd, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic